Rapamycin, Approved to Prevent Transplant Rejection, Can Decrease Alcohol Cravings, Ernest Gallo Clinic and Research Center and University of California, San Francisco (UCSF) Study

Physorg -- Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents. The finding is in a study by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.